X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences (48) 48
humans (38) 38
hematology (34) 34
oncology (32) 32
index medicus (31) 31
aged (25) 25
immunology (25) 25
male (24) 24
middle aged (22) 22
lymphomas (15) 15
[ sdv.imm ] life sciences [q-bio]/immunology (14) 14
female (14) 14
cancer (13) 13
adult (12) 12
lymphoma (12) 12
rituximab (12) 12
treatment outcome (12) 12
[ sdv ] life sciences [q-bio] (11) 11
antineoplastic agents - therapeutic use (11) 11
chronic lymphocytic leukemia (11) 11
[sdv]life sciences [q-bio] (10) 10
hemic and lymphatic diseases (10) 10
medicine & public health (10) 10
mesh : humans (10) 10
[sdv.imm]life sciences [q-bio]/immunology (9) 9
mesh : aged (9) 9
chemotherapy (8) 8
combined modality therapy (8) 8
human health and pathology (8) 8
medicine (8) 8
immunotherapy (7) 7
leukemia (7) 7
multiple myeloma (7) 7
neoplasms. tumors. oncology. including cancer and carcinogens (7) 7
prognosis (7) 7
tumors (7) 7
antineoplastic agents (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
care and treatment (6) 6
cyclophosphamide (6) 6
ofatumumab (6) 6
recurrence (6) 6
remission induction (6) 6
aged, 80 and over (5) 5
antibodies, monoclonal - therapeutic use (5) 5
antimitotic agents (5) 5
b-cell lymphoma (5) 5
chronic lymphocytic-leukemia (5) 5
cll (5) 5
health aspects (5) 5
mesh : adult (5) 5
mesh : middle aged (5) 5
multiple myeloma - therapy (5) 5
patients (5) 5
pharmacy (5) 5
survival (5) 5
transplantation, autologous (5) 5
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (4) 4
[sdv.can]life sciences [q-bio]/cancer (4) 4
adolescent (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
b cells (4) 4
biotechnology & applied microbiology (4) 4
bone marrow (4) 4
child (4) 4
diagnosis (4) 4
expression (4) 4
granulocyte colony-stimulating factor - therapeutic use (4) 4
immune system diseases (4) 4
leukemia, lymphocytic, chronic, b-cell - drug therapy (4) 4
lymphoma - therapy (4) 4
medical prognosis (4) 4
mesh : female (4) 4
mesh : male (4) 4
mesh : treatment outcome (4) 4
non-hodgkin's lymphomas (4) 4
oncotargets and therapy (4) 4
open-label (4) 4
polymorphism (4) 4
research (4) 4
retrospective studies (4) 4
therapy (4) 4
toxicity (4) 4
transplantation (4) 4
[ sdv.can ] life sciences [q-bio]/cancer (3) 3
analysis (3) 3
antibodies, monoclonal - pharmacology (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
antigens (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
apoptosis (3) 3
article (3) 3
b-lymphocytes - drug effects (3) 3
b-lymphocytes - immunology (3) 3
b-lymphocytes - metabolism (3) 3
bendamustine (3) 3
biomarkers (3) 3
case report (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical reviews in allergy & immunology, ISSN 1080-0549, 05/2019, pp. 1 - 17
Approved for the treatment of autoimmune diseases, hematological malignancies, and solid cancers, several monoclonal antibodies (mAb) make use of complement in... 
Animal models | Complement inhibitors | Target recognition | Hematology | Toxicity | Medical treatment | Immunoglobulin G | Medical services | Cytotoxicity | Activation | Complement | Optimization | Complement component C1q | Complement activation | Immunotherapy | Monoclonal antibodies | Mutation | Autoimmune diseases | Life Sciences | Immunology
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 05/2016, Volume 8, Issue 5, pp. 569 - 81
Over the last two decades, anti-CD20 monoclonal antibody (mAb) therapy has improved patient outcome in B-cell malignancies, and confirmed CD20 as an important... 
Life Sciences | Immunology
Journal Article
OncoTargets and Therapy, ISSN 1178-6930, 2019, Volume 12, pp. 1181 - 1184
Richter syndrome (RS) is an aggressive lymphoma arising on the back of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and is the most... 
Chronic lymphocytic leukemia | Richter syndrome | Small lymphocytic lymphoma | Idelalisib | chronic lymphocytic leukemia | small lymphocytic lymphoma | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CHRONIC LYMPHOCYTIC-LEUKEMIA | idelalisib | Genotype & phenotype | Lymphatic system | Hospitals | Biopsy | Leukemia | Systematic review | Lymphomas | Patients | Life Sciences
Journal Article
by Trotman, Judith and Barrington, Sally F and Belada, David and Meignan, Michel and MacEwan, Robert and Owen, Carolyn and Ptáčník, Václav and Rosta, András and Fingerle-Rowson, Günter R and Zhu, Jiawen and Zhu, Jun and Nielsen, Tina and Sahin, Deniz and Hiddemann, Wolfgang and Marcus, Robert E and Davies, Andrew and Hertzberg, Mark and Grigg, Andrew and Cannell, Paul and Quach, Hang and Opat, Stephen and Tam, Constantine and Marlton, Paula and Janssens, Ann and Offner, Fritz and Van eygen, Koen and Sangha, Randeep and Mckay, Pam and Wilson, Jonathan and Van Der Jagt, Richard and Roitman, Daryl and Trneny, Marek and Mayer, Jiri and Le Du, Katell and Solal-Celigny, Philippe and Cartron, Guillaume and Foussard, Charles and Frickhofen, Norbert and Schmidt, Peter and Graeven, Ullrich and Gaska, Tobias and Schlag, Rudolf and Sökler, Martin and Prange-Krex, Gabriele and Florschütz, Axel and Lindemann, Hans-Walter and Schimmelpfennig, Christoph and Tonndorf, Solveig and Hänel, Mathias and Hess, Georg and Schalk, Enrico and Hütten, Heiko and Doelken, Gottfried and Pfreundschuh, Michael and Keller, Ulrich and Herold, Michael and Forstpointner, Roswitha and Vehling-Kaiser, Ursula and Hoffmann, Martin and Borbenyi, Zita and Udvardy, Miklos and Demeter, Judit and Rambaldi, Alessandro and Morra, Enrica and Massimo, Federico and Majolino, Ignazio and Balzarotti, Monica and Semenzato, Gianpietro and Canales Albendea, Miguel Angel and Peñalver Parraga, Francisco Javier and Soler Campos, Alfonso and Sancho Cia, Juan Manuel and Marquez Navarro, Jose Antonio and Grande Garcia, Carlos and Nilsson-Ehle, Herman and Mccarthy, Helen and Pocock, Chris and Sadullah, Shalal and Malladi, Ram and Radford, John and Kanfer, Ed and Kruger, Anton and Culligan, Dominic and Dyer, Martin and Pettengell, Ruth and Seymour, John and Gribben, John and Al-Ismail, Saad and Al-Refaie, Faris and Blesing, Norbert and Macnamara, Christopher and O'callaghan, Ann and Haynes, Andrew and Follows, George and Johnson, Roderick and Cunningham, David and Bowles, Kristian and Collins, Graham and Gallop-Evans, Eve and Robinson, Stephen and ... and PET investigators GALLIUM study and PET investigators from the GALLIUM study
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1530 - 1542
Initial results from the ongoing GALLIUM trial have shown that patients with follicular lymphoma have a longer progression-free survival after first-line... 
FDG-PET | CRITERIA | FONDAZIONE ITALIANA LINFOMI | SUBSET ANALYSIS | POSITRON-EMISSION-TOMOGRAPHY | INTERNATIONAL WORKSHOP | THERAPY | ONCOLOGY | PROGRESSION-FREE SURVIVAL | FOLL05 TRIAL | MINIMAL RESIDUAL DISEASE | Pets | Lymphomas | Prognosis | Analysis
Journal Article
JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN 2051-1426, 04/2019, Volume 7, Issue 1, pp. 111 - 13
Background: Dysregulation in calcium (Ca2+) signaling is a hallmark of chronic lymphocytic leukemia (CLL). While the role of the B cell receptor (BCR) Ca2+... 
CELLS | CLL | CA2+ ENTRY | ACTIVATION | STIM1 | ONCOLOGY | Disease outcome | GROWTH | IMMUNOLOGY | Constitutive Ca2+ entry | Viral antibodies | Chronic lymphocytic leukemia | Care and treatment | Usage | Antibodies | Cell membranes | B cells | Research | Medical prognosis | Leukemia | Cloning | Epigenetics | Kinases | Cancer | Cell adhesion & migration | Life Sciences
Journal Article
Critical Reviews in Clinical Laboratory Sciences, ISSN 1040-8363, 07/2019, Volume 56, Issue 5, pp. 321 - 332
Increased resistance to apoptosis represents a key oncogenic mechanism in chronic lymphocytic leukemia (CLL) that has been attributed to the upregulation of... 
BH3-mimetics | apoptosis | CLL | B-CELL RECEPTOR | BCL2 INHIBITOR NAVITOCLAX | DNA HYPOMETHYLATION | NOXA/MCL-1 BALANCE | DRUG-RESISTANCE | ANTITUMOR-ACTIVITY | NURSE-LIKE CELLS | CLL CELLS | TARGETING BCL2 | BASIC SCIENCE | MEDICAL LABORATORY TECHNOLOGY | Life Sciences | Immunology
Journal Article